PRESSURE BIOSCIENCES, INC. (OTCMKTS:PBIO) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07 Submission of Matters to a Vote of Security Holders.
On December 21, 2017, Pressure BioSciences, Inc. (the “Company”) held a special meeting in lieu of the annual meeting of stockholders (the “Meeting”). At the Meeting, the stockholders voted on the following proposals described in detail in the Company’s definitive proxy statement for the Meeting filed with the Securities and Exchange Commission on November 17, 2017. As of the record date for the Meeting, there were 1,161,049 shares of the Company’s common stock, par value $0.01 per share, issued and outstanding and entitled to one vote for each share held. The holders of 64.06% of the Company’s shares of common stock outstanding (743,726) submitted votes by proxy or in person at the Meeting, constituting a quorum.
Proposal 1 — Elect one director as a Class III Directors until the 2020 Annual Meeting of Stockholders. The election of the director was approved as follows:
| Shares voted | ||||
| Nominee | For | Against | Withheld | Broker Non-Votes |
| Richard T. Schumacher | 259,188 | N/A | 7,893 | 476,645 |
Proposal 2: Ratify the appointment of MaloneBailey LLP as the Company’s independent auditors for fiscal year 2017. The ratification of the appointment of MaloneBailey LLP as the Company’s independent auditor for fiscal year 2017 was approved as follows:
| Shares voted | |
| For | 731,133 |
| Against | 5,531 |
| Abstain | 7,062 |
| Broker Non-Votes | N/A |
Proposal 3: Approval of an adjournment of the Meeting, if necessary or appropriate, to solicit additional proxies, in the event that there are not sufficient votes at the time of such adjournment to approve any of Proposal Nos. 1 through 2. The adjournment was approved as follows:
| Shares voted | |
| For | 705,012 |
| Against | 31,524 |
| Abstain | 7,190 |
| Broker Non-Votes |
About PRESSURE BIOSCIENCES, INC. (OTCMKTS:PBIO)
Pressure BioSciences, Inc. is focused on solving the problems inherent in biological sample preparation. The Company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels, such as approximately 35,000 pounds per square inch (psi) or greater to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources. Its laboratory instrument, the Barocycler, and its consumables product line, which include its Pressure Used to Lyse Samples for Extraction (PULSE) tubes, and other processing tubes, and application specific kits, such as consumable products and reagents, together make up its PCT Sample Preparation System (PCT SPS). The Company is also the distributor for the Constant Systems cell disruption equipment, parts, and consumables.